🔎 Trials Near Me

Dachaigh › Rhabdomyosarcoma › California

Sgrùdaidhean clionaigeach Rhabdomyosarcoma ann an California

Tha 7 sgrùdaidhean airson Rhabdomyosarcoma a’ lorg phàirtichean aig làraichean ann an California.

Teacsa sgrùdaidh oifigeil (Beurla)

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • UCSF Benioff Children's Hospital, San Francisco
A’ fastadhÌre 1
24 Months – 18 Years · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06441331

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • UCSF Benioff Children's Hospital Oakland, Oakland
  • Rady Children's Hospital, San Diego
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06541262

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

  • City of Hope Comprehensive Cancer Center, Duarte
  • Loma Linda University Medical Center, Loma Linda
  • Cedars-Sinai Medical Center, Los Angeles
  • agus 4 a bharrachd
A’ fastadhÌre 3
Suas gu aois 50 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07466316

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

  • Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT07628634

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, San Francisco, San Francisco
A’ fastadhÌre 1/2
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06721689

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

  • Stanford University, Palo Alto
A’ fastadhÌre 2
Suas gu aois 22 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT06023641

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Lucille Packard Children's Hospital Stanford, Palo Alto
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04901702

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.